Trending...
- RockNTix takes on the ticketing monopoly with a view to abolishing service fees - 111
- Prime Healthcare Celebrates Patient Safety Excellence Recognition from Healthgrades
- San Jose: : Be a City of San José Board or Commission Member
CARLSBAD, Calif. - Californer -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput microbial WGS library preparation kit enabling 2nd-generation short-read sequencers to produce long-range results in a much affordable price for microbial genomes.
With this special high throughput kit, users can pool more microbial samples in one sequencing run in combination with our 96-well plate multiplexing primers, which includes 10-base indexes and significantly reduces NGS library preparation and sequencing costs.
Researchers will now be able to take advantage of the ultra-long linked-read results to provide unparalleled genomic information with up to 200Kb gDNA fragments for microbial genome analyses.
With TELL-Seq technology, we've made NGS library preparation easy. Our products effectively improve performance, process time, and budget across a broad range of sample types with a proven track record.
Dr. Tom Chen, Chief Scientific Officer of UST, stated, "We are further streamlining the TELL-seq workflow with reduced cost per reaction and expanded throughput in response to increased customer demands."
More on The Californer
UST's TELL-Seq is a patent-pending transposase-based linked-read library preparation technology that enables short-read 2nd generation DNA sequencing platforms, such as Illumina sequencers, to produce long-range sequencing results (averaging linked-read molecule length greater than 40kb and up to 200kb). With a simple workflow, a sequencing-ready Illumina library can be prepared in PCR tubes in about 3 hours, cost-effective and no special lab equipment needed.
ABOUT UST
Universal Sequencing Technology Corporation (UST), a Boston and San Diego-based NGS biotechnology company, was established by a group of NGS veterans. UST is dedicated to developing the most advanced DNA sequencing technologies and has filed more than 20 PCT patent applications covering linked read NGS library preparation, single-cell sequencing, and groundbreaking 3rd-generation DNA sequencing technologies. UST is poised to lead the next wave of DNA sequencing innovations.
www.universalsequencing.com
With this special high throughput kit, users can pool more microbial samples in one sequencing run in combination with our 96-well plate multiplexing primers, which includes 10-base indexes and significantly reduces NGS library preparation and sequencing costs.
Researchers will now be able to take advantage of the ultra-long linked-read results to provide unparalleled genomic information with up to 200Kb gDNA fragments for microbial genome analyses.
With TELL-Seq technology, we've made NGS library preparation easy. Our products effectively improve performance, process time, and budget across a broad range of sample types with a proven track record.
Dr. Tom Chen, Chief Scientific Officer of UST, stated, "We are further streamlining the TELL-seq workflow with reduced cost per reaction and expanded throughput in response to increased customer demands."
More on The Californer
- Quotehunt.co.uk: Revolutionising the UK B2B Market with Comprehensive Comparison Services for Small Businesses
- The 2nd Aollywood Five Continents Film Festival Nominations Were Announced: "All Quiet on the Western Front" Led With 7 Nominations
- Human Matriptase/ST14 Protein (High Purity)
- Myristoyl-Coenzyme A (Highly Pure)
- Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC , a partner of Veterans for Trump
UST's TELL-Seq is a patent-pending transposase-based linked-read library preparation technology that enables short-read 2nd generation DNA sequencing platforms, such as Illumina sequencers, to produce long-range sequencing results (averaging linked-read molecule length greater than 40kb and up to 200kb). With a simple workflow, a sequencing-ready Illumina library can be prepared in PCR tubes in about 3 hours, cost-effective and no special lab equipment needed.
ABOUT UST
Universal Sequencing Technology Corporation (UST), a Boston and San Diego-based NGS biotechnology company, was established by a group of NGS veterans. UST is dedicated to developing the most advanced DNA sequencing technologies and has filed more than 20 PCT patent applications covering linked read NGS library preparation, single-cell sequencing, and groundbreaking 3rd-generation DNA sequencing technologies. UST is poised to lead the next wave of DNA sequencing innovations.
www.universalsequencing.com
Source: Universal Sequencing Technology Corporation
0 Comments
Latest on The Californer
- The Nashville International Chopin Piano Competition Announces the Alexei Sultanov Memorial Discovery Prize
- Available Medicare Advantage Plans 2023 Increased By 6 Percent
- Kobie Voted a Top Workplace USA
- Aquia Inc. Joins the AWS Partner Network and the AWS Public Sector Partner Program
- PatientClick launched Hybrid Medical Billing Services
- Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing
- Databloom's Blossom Achieves Faster and More Efficient Big Data Analytics
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Block, Inc. (SQ) on Behalf of Investors
- How garbage collection in Erlang helps us to create scalable applications
- Tencent Cloud Shines Spotlight on Affordable AAA Game Tech for Everyone at 2023 Game Developers Conference USA - English APAC - English
- Mix Engineer Rob Chiarelli Enjoying Another #1 Gospel Hit with "Finished" by Tamela Mann
- Tanktwo Releases Case Study: Helping a Primary Defense Contractor Accelerate Electrification
- YourPawsandMine.com Launches Their Brand Website As The Predominant Place To Shop For Cats And Dogs
- Orchard Audio's New PecanPi®+ DAC and Streamer Feature AKM's Latest Flagship Chips
- Country Artist Ashley Wineland to Release Poignant Ballad 'I'm Going Home'; Announces Her 2023 National Tour
- Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference
- Doug Brownridge Joins STS Capital Partners
- BOOST Conference Celebrates 15 Years of Learning for Educators & Professionals Supporting Youth
- WebPurify Hires Twitter's Former Head of Trust and Safety Operations
- RockNTix takes on the ticketing monopoly with a view to abolishing service fees